Target intelligence / Profile preview

Myosin VB pseudogene 2 (MYO5BP2)

Target: MYO5BP2
Molecular classification: Other (Pseudogene)

Overview

Myosin VB pseudogene 2 (MYO5BP2) is annotated as a pseudogene, meaning it is a genomic DNA sequence similar to a protein-coding gene but generally non-functional and not translated into a functional protein. As a member of the myosin VB gene family, it shares sequence similarity with genes encoding myosin class V molecular motors, but lacks protein-coding potential and has no established biological functions or roles in disease[2]. There is no evidence to suggest it is involved in any active cellular process, is implicated in disease, or is a therapeutic target.

Other names: MYO5BP2

Beyond the preview

Go deeper on Myosin VB pseudogene 2 (MYO5BP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myosin VB pseudogene 2 (MYO5BP2).

Explore the full profile